131 related articles for article (PubMed ID: 2349680)
41. Cyclosporine measurement in transplantation.
Sanghvi A; Seltman H; Diven W
Arch Pathol Lab Med; 1985 Dec; 109(12):1072-5. PubMed ID: 3907588
[TBL] [Abstract][Full Text] [Related]
42. Experiences with a blood level-adjusted cyclosporine regimen in kidney and liver allograft recipients.
Wonigeit K; Hoyer PF; Schumann G; Ringe B; Frei A; Picklmayr R
Transplant Proc; 1986 Dec; 18(6 Suppl 5):181-7. PubMed ID: 3538568
[No Abstract] [Full Text] [Related]
43. Cyclosporine levels in whole blood. Comparison of the polyclonal Sandoz Ciclosporin Radioimmunoassay Kit with the specific antibody in the new Sandimmun Kit.
Jones SR; Gunson B; McLean S; McMaster P; Ratcliffe JG
Transplantation; 1988 May; 45(5):991-2. PubMed ID: 3285548
[No Abstract] [Full Text] [Related]
44. Cyclosporine monitoring with polyclonal and specific monoclonal antibodies during episodes of renal allograft dysfunction.
Holt DW; Marsden JT; Johnston A; Taube DH
Transplant Proc; 1989 Feb; 21(1 Pt 2):1482-4. PubMed ID: 2652475
[No Abstract] [Full Text] [Related]
45. Comparison of cyclosporine A dosage and metabolism in liver and heart transplant recipients.
Hamilton G; Mühlbacher F; Roth E; Wolf I; Piza F; Havel M; Laczkovics A; Schindler J; Wolosczuk W
Transplant Proc; 1987 Feb; 19(1 Pt 2):1706-8. PubMed ID: 3547878
[No Abstract] [Full Text] [Related]
46. Consensus statements on the optimal use of cyclosporine in pediatric patients.
Brodehl J
Transplant Proc; 1994 Oct; 26(5):2759-62. PubMed ID: 7940869
[No Abstract] [Full Text] [Related]
47. Cyclosporine--high-dose steroid interaction in renal transplant recipients: assessment by HPLC.
Ptachcinski RJ; Venkataramanan R; Burckart GJ; Hakala TR; Rosenthal JT; Carpenter BJ; Taylor RJ
Transplant Proc; 1987 Feb; 19(1 Pt 2):1728-9. PubMed ID: 3274417
[No Abstract] [Full Text] [Related]
48. Absence of class II major histocompatibility complex antigen induction in cyclosporine A--treated recipients of heart and kidney allografts in the rat.
Milton AD; Spencer SC; Fabre JW
Transplant Proc; 1987 Feb; 19(1 Pt 1):192-4. PubMed ID: 3152686
[No Abstract] [Full Text] [Related]
49. Interaction of calcium blockers and cyclosporine.
Wagner K; Henkel M; Heinemeyer G; Neumayer HH
Transplant Proc; 1988 Apr; 20(2 Suppl 2):561-8. PubMed ID: 3284103
[No Abstract] [Full Text] [Related]
50. Cyclosporine blood level measurements with mono- and polyclonal antibodies during clinical renal transplantation.
Foradori AC; Martinez L; Loveluck A; Correa L; Rodriguez L
Transplant Proc; 1989 Feb; 21(1 Pt 2):1486. PubMed ID: 2652477
[No Abstract] [Full Text] [Related]
51. Cyclosporin drug monitoring: comparison of four immunoassays and HPLC.
Kunzendorf U; Brockmöller J; Jochimsen F; Keller F; Roots I; Walz G; Offermann G
Klin Wochenschr; 1989 Apr; 67(8):438-41. PubMed ID: 2657205
[TBL] [Abstract][Full Text] [Related]
52. Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.
Awni WM; Heim-Duthoy K; Kasiske BL
Transplant Proc; 1990 Jun; 22(3):1343-4. PubMed ID: 2349693
[No Abstract] [Full Text] [Related]
53. Comparative study of different methods for measuring blood cyclosporine A levels in kidney transplantation.
Sabater J; Quereda C; Marcen R; Orofino L; Herrera I; Muñoz ML; Villafruela JJ; Ortuño J
Transplant Proc; 1990 Aug; 22(4):1720-2. PubMed ID: 2202129
[No Abstract] [Full Text] [Related]
54. Tailoring cyclosporine according to kinetic profiles: does it allow a low-dose therapeutic schedule?
Segoloni GP; Triolo G; Squiccimarro G; Colla L; Turello E; Aimo G; Pecchio F; Vercellone A
Transplant Proc; 1987 Feb; 19(1 Pt 2):1726-7. PubMed ID: 3274416
[No Abstract] [Full Text] [Related]
55. Comparison of two radioimmunoassay kits for the determination of cyclosporine concentrations in transplantation.
Wong PY; Mee AV; Taylor G; Uchimaru D; Sun C; Alspector F
Transplant Proc; 1988 Apr; 20(2 Suppl 2):348-53. PubMed ID: 3284079
[No Abstract] [Full Text] [Related]
56. Clinical transplantation--overview.
Beveridge T
Prog Allergy; 1986; 38():269-92. PubMed ID: 3523492
[No Abstract] [Full Text] [Related]
57. Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.
van Gelder T; Knoop CJ; Hesse CJ; Vaessen LM; Balk AH; Yzermans JN; Weimar W
Transplant Proc; 1995 Feb; 27(1):856-8. PubMed ID: 7879206
[No Abstract] [Full Text] [Related]
58. Cyclosporine A monitoring by radioimmunoassay (RIA) and high-performance liquid chromatography (HPLC) after liver transplantation: influence of route of administration and of liver function on the RIA:HPLC ratio.
Oldhafer KJ; Schumann G; Wonigeit K; Oellerich M; Ringe B; Pichlmayr R
Transplant Proc; 1988 Jun; 20(3 Suppl 3):361-5. PubMed ID: 3291268
[No Abstract] [Full Text] [Related]
59. Cyclosporine measurement by FPIA, PC-RIA, and HPLC following liver transplantation.
Burckart GJ; Jain A; Diven W; Venkataramanan R; Starzl TE
Transplant Proc; 1990 Jun; 22(3):1319-22. PubMed ID: 2190393
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics of cyclosporine A in bilateral lung transplantation candidates with cystic fibrosis.
Mancel-Grosso V; Bertault-Peres P; Barthelemy A; Chazalette JP; Durand A; Noirclerc M
Transplant Proc; 1990 Aug; 22(4):1706-7. PubMed ID: 2389438
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
